Evotec strikes an R&D deal focused on addiction – FierceCRO
0
The R&D innovators at Evotec have signed a deal to lend their drug discovery muscle to U.K. biotech C4X Discovery, hoping to develop selective drugs that can combat addiction without druggy side effects.
Under the agreement, Evotec will apply its discovery platform–which includes a sizable molecule database and screening technology to crawl it–and help C4XD get moving on drugs that block the body’s orexin neurotransmitters.
Read more – FierceCRO